Abstract
Atrial fibrillation (AF) is considered one of the most common clinically relevant cardiac arrhythmias. The prevalence of AF increases with age and is reported to be 0.2%–0.3% at age 25 – 35 years, 3%–4% at age 55 – 64 years, and 5%–9% at age 62 – 90 years (1). AF is usually a consequence of heart disease involving the left atrium, but may also result from extracardiac conditions such as hyperthyroidism, surgery, acute alcohol intoxication, cholinergic drug use, or diagnostic procedures. In a minority of patients, no contributing factors or overt heart disease can be identified (lone AF). In most cases the clinical and hemodynamic consequences of AF are related to the severity of underlying heart disease.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Kannel WB, Wolf PA (1992) Epidemiology of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation. Mechanisms and management. Raven, New York, pp 81–92
Ruskin J, McHale PA, Harley A, Greenfield JC Jr (1970) Pressure-flow studies in man: effects of atrial systole on left ventricular function. J Clin Invest 49: 472–478
Atwood JE (1992) Exercise hemodynamics of atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation. Mechanism and management. Raven, New York, pp 145–163
Rahimtoola SH, Ehsani A, Sinno MZ et al (1975) Left atrial transport function in myocardial infarction: importance of its booster function. Am J Med 59: 686–693
Greenberg B, Chatterjee K, Parmley WW, Werner JA, Holly AN (1980) The influence of left ventricular filling pressure on atrial contribution to cardiac output. Am Heart J 98: 742751
Pehrsson SK (1983) Influence of heart rate and atrioventricular synchronization on maximal work tolerance in patients treated with artificial pacemaker. Acta Med Scand 214: 311–315
Ausubel K, Steingart RM, Shimshi M, Klementowicz P, Furman S (1985) Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility. Circulation 72: 1037
Fananapazir L, Bennet DH, Monks P (1983) Atrial synchronized ventricular pacing: contribution of the chronotropic response to improved exercise performance. Pace 6: 601–605
Fananapazir L, Srinivas V, Bennet DH (1983) Comparison of resting hemodynamic indices and exercise performance during atrial synchronized and asynchronous ventricular pacing. Pace 6: 202–206
Naito M, David D, Michelson EL, Schaffenburg M, Dreifus LS (1983) The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model. Am Heart J 106: 284–291
Piccolo E, Di Pede F, Millosevich P (1993) Ablazione transcatetere della giunzione AV ed impianto di Pace-Maker in pazienti con fibrillazione e flutter atriale: la regolarizzazione dei cicli ventricolari migliora la funzione cardiaca? In: Piccolo E, Raviele A (eds) Third International Workshop on Cardiac Arrythmias, Venice, 21–23 October 1993. Centro Scientifico Editore, Torino, pp 79–92
Packer DL, Bardy GH, Worley SJ, Smith MS, Cobb FR, Coleman E, Gallagher JJ, German LD (1986) Tachycardia-induced cardiomyopathy: a reversible form of left ventricular dysfunction. Am J Cardiol 57: 563–570
McLaran CJ, Gersh Bi, Sugrue DD, Hammill SC, Seward JB, Holmes DR Jr (1985) Tachycardia induced myocardial dysfunction: a reversible phenomenon? Br Heart J 53: 323–327
Leather RA, Kerr CR (1992) Atrial fibrillation in the absence of overt cardiac disease. In: Falk RH, Podrid PJ (eds) Atrial fibrillation: mechanisms and management. Raven, New York, pp 93–108
Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69: 1570–1573
Selzer A (1960) Effects of atrial fibrillation upon the circulation in patients with mitral stenosis. Am Heart J 59: 518–526
Graettinger JS, Carleton RA, Muenster JJ (1964) Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct-current shock. J Clin Invest 43: 2290–2295
Morris JJ, Entman M, North WC et al (1965) The changes in cardiac output with reversion of atrial fibrillation to sinus rhythm. Circulation 31: 670–678
Reale A (1965) Acute effects of countershock conversion of atrial fibrillation upon right and left heart hemodynamics. Circulation 32: 214–222
Killip T, Baer R (1965) Hemodynamic effect after reversion from atrial fibrillation to sinus rhythm by precordial shock. J Clin Invest 45: 658–670
Shapiro W, Klein G (1968) Alterations in cardiac function immediately following electrical conversion of atrial fibrillation to normal sinus rhythm. Circulation 38: 1074–1078
Glancy DL, O’Brein KP, Gold HK et al (1970) Atrial fibrillation in patients with idiopatic hypertrophie subaortic stenosis. Am Heart J 32: 652–658
Di Pede F, Raviele A, Zuin G et al (1987) Quando, come e perché riconverire a ritmo una fibrillazione atriale. In: Raviele A, Alboni P (eds) Third International Workshop on Cardiac Arrythmias, Venice, 21–23 October 1993. 11 Pensiero Scientifico Editore, Rome, pp 55–62
Piccolo E, Delise P, Alboni P et al (1991) Problemi elettrofisiologici e clinici della fibrillazione atriale. G Ital Cardiol 21: 437–459
Scarfò S, Papparella N, Fucà G, Yannacopulu P, Alboni P (1993) Perché conquistare a tutti i costi it ritmo sinusale? Quale vantaggio emodinamico per it paziente? G Hal Cardiol 23 [Sup-pl I]: 98–102
Atwood JE, Myers J, Sullivan M et al (1988) Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation. J Am Coll Cardiol 11: 508–513
Manning W, Leeman DE, Gotch PJ, Come PC (1989) Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 13: 617–623
Pollick C (1992) Echocardiography in atrial fibrillation. In: Falk RH, Podrid PJ (eds) Atrial fibrillation: mechamisms and management. Raven, New York, pp 165–180
Sanfilippo AJ, Abascal VM, Sheehan M et al (1990) Atrial enlargement has a consecuence of atrial fibrillation. A prospective echocardiographic study. Circulation 82: 791–797
Van Gelder IC, Crijns HJ, Van Gilst WH, Hamer HPM, Lie KI (1991) Decrease of right and left atrial size after direct current electrical cardioversion in chronic atrial fibrillation. Am J Cardiol 67: 93–95
Hinton RC, Kistler JP, Fallon JT, Friedlich AL, Fisher CM (1977) Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Cardiol 40: 509–513
Wolf PA, Dawber TR, Thomas HE, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28: 973–977
Albers GW, Atwood JE, Hirsh J, Sherman DG, Hughes RA, Connolly SJ (1991) Stroke prevention in nonvalvular atrial fibrillation. Ann Intern Med 115: 727–736
Wolf PA, Abbott RD, Kannel WB (1987) Atrial fibrillation: major contributor to stroke in the elderly. Arch Intern Med 147: 1561–1564
Stroke Prevention in Atrial Fibrillation Study Group Investigators (1990) Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. N Engl J Med 322: 863–868
Fisher CM (1979) Reducing risk of cerebral embolism. Geriatrics 34: 59–66
Stroke Prevention in Atrial Fibrillation Investigators (1992) Predictors of thromboembolism in atrial fibrillation. I. Clinical features of patients at risk. Ann Intern Med 116: 1–5
Flegel KM, Hanley J (1989) Risk factors for stroke and other embolic events in patients with nonrheumatic atrial fibrillation. Stroke 20: 1000–1004
Cairns JA, Connolly SJ (1991) Nonrheumatic atrial fibrillation: risk of stroke and role of antithrombotic theraphy. Circulation 84: 469–481
Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306: 1018–1022
Onundarson PT, Thorgeirsson G, Jonmundsson E, Sigfusson N, Hardson T (1987) Chronic atrial fibrillation — epidemiologic features and 14 year follow-up: a case control study. Eur Heart J 3: 521–527
Kitchin AH, Milne JS (1977) Longitudinal survey of ischaemic heart disease in randomly selected sample of older population. Br Heart J 39: 889–893
Petersen P, Boysen G, Godtfredsen J, Andersen E, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. Lancet 1: 175–178
The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators (1990) The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 323: 1505–1511
Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke prevention in atrial fibrillation study. Final results. Circulation 84: 527–539
Evans W, Swann P (1954) Lone auricular fibrillation. Br Heart J 16: 189–194
Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR, Ilstrup DM, Frye RL (1987) The natural history of lone atrial fibrillation. N Engl J Med 317: 669–674
Gajewski J, Singer RB (1981) Mortality in an insured population with atrial fibrillation. JAMA 245: 1540–1544
Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN (1993) The influence of atrial fibrillation on prognosis in mild to moderate heart failure. Circulation 87 [Suppl VI]: 102–110
Middlekauff HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84: 40–48
Keogh AM, Baron DW, Hickie JB (1990) Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 65: 903–908
Unverferth DV, Magorien RD, Moescberger ML, Baker PB, Fetters JK, Leier CV (1984) Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol 54: 147–152
Cameron A, Schwartz MJ, Kronmal RA, Kosinski AS (1988) Prevalence and significance of atrial fibrillation in coronary artery disease ( CASS Registry ). Am J Cardiol 61: 714–717
Kannel WB, Abbott RD, Savage DD, McNamara PM (1983) Coronary heart disease and atrial fibrillation: the Framingham study. Am Heart J 106: 389–396
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Italia, Milano
About this paper
Cite this paper
Di Pede, F., Zuin, G. (1996). Is Mortality in Patients with Atrial Fibrillation Related to the Underlying Heart Disease or to the Arrhythmia?. In: Raviele, A. (eds) Cardiac Arrhythmias 1995. Springer, Milano. https://doi.org/10.1007/978-88-470-2223-2_39
Download citation
DOI: https://doi.org/10.1007/978-88-470-2223-2_39
Publisher Name: Springer, Milano
Print ISBN: 978-3-540-75012-3
Online ISBN: 978-88-470-2223-2
eBook Packages: Springer Book Archive